Last modified: January 8, 2010
Offices[edit]
People[edit]
Web Presences[edit]
- Biotech & Life Sciences
Industries[edit]
Parent Company[edit]
Acquisitions / Subsidiaries[edit]
Paid Sources[edit]
Keywords[edit]
|
|
Description[edit]
OUR MISSION: Our mission is to become a leader in the discovery and development of next generation antibodies for the treatment of cancer and other diseases with unmet medical need.
Affimed is a private biopharmaceutical company specializing in the development of recombinant antibodies. The Company’s powerful research engine, based around three distinct antibody libraries and proprietary antibody formats, is driving the development of a strong, broad portfolio of antibodies that target cancer and other diseases. The unique properties of these libraries allows Affimed to identify antibodies against even the most difficult of targets. Affimed’s proprietary antibody formats include ’TandAbs™’, unique tetravalent antibodies that are particularly well suited to targeting tumor cells. Affimed’s two most advanced therapeutic programs, in late preclinical development, comprise TandAbs™ leads in Non-Hodgkin’s Lymphoma and Hodgkin’s Disease. Affimed is based in Heidelberg, Germany.
Innovation[edit]
Activities[edit]
| Jobs by SimplyHired |
- No jobs were found for this particular company. Please visit the job board to search for more.
| Affimed Job Trends | Affimed Jobs |
- Biotech Showcase 2010 - Presenting Companies (2 subscribers)
This Company is Being Watched in
Recent Updates |
|---|
| Affimed has been added to the Ecosystem. |